123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients

NCT01737112 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Thyroid Cancer and (FDG)PET/CT Scan

NCT04128631 ·Status: UNKNOWN

NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG

NCT02027831 ·Status: UNKNOWN ·Phase: PHASE2

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

NCT07132645 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer

NCT01359267 ·Status: COMPLETED ·Phase: EARLY_PHASE1

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

NCT03107663 ·Status: COMPLETED ·Phase: PHASE1

Development of Photoacoustic Tomography

NCT03501823 ·Status: UNKNOWN

[18F]-AraG PET Imaging in LA HNSCC

NCT07168785 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma

NCT01943097 ·Status: UNKNOWN

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8

NCT05940298 ·Status: COMPLETED ·Phase: PHASE1

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

NCT06858501 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT

NCT00256490 ·Status: COMPLETED ·Phase: NA

Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors

NCT02691078 ·Status: COMPLETED ·Phase: PHASE2

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA

NCT00373711 ·Status: WITHDRAWN

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

NCT04258592 ·Status: TERMINATED ·Phase: PHASE1

Imaging Study for FdCyd and THU Cancer Treatment

NCT01479348 ·Status: TERMINATED ·Phase: EARLY_PHASE1

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

NCT00019565 ·Status: COMPLETED ·Phase: PHASE1

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

NCT02174679 ·Status: NO_LONGER_AVAILABLE

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

NCT04161781 ·Status: COMPLETED

Clinical Application of 99mTc-FDPH46 SPECT/CT Imaging in Malignant Solid Tumor: a Prospective Exploratory Study

NCT06753513 ·Status: NOT_YET_RECRUITING

68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis

NCT02560376 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma

NCT00498667 ·Status: WITHDRAWN

Interest of Whole-body MRI Correlated to Spreading Sequences for Staging Neuroendocrine Tumors

NCT02786303 ·Status: UNKNOWN ·Phase: NA

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

NCT02317393 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

NCT05534594 ·Status: COMPLETED ·Phase: NA